Chembio Diagnostics, Inc. (NASDAQ:CEMI) developer of diagnostic tests that detect infectious diseases, is reporting third quarter earnings results on Thursday 5th November 2020, after market close.
The consensus estimates from Thomson Reuters are loss of $ 0.26 per share.
For the full year, analysts predict revenues of $ 21.08 million, while looking forward to loss of $ 1.17 per share.
Previous Quarter Performance
Chembio Diagnostics, Inc. came out with loss for the second quarter of $ 0.42 per share, from the revenue of $ 5.11 million. The quarterly revenues reduced 46.72 percent compared with the same quarter last year. Wall street analysts are predicting, CEMI to report 2Q20 loss of $ 0.39 per share from revenue of $ 6.88 million. The bottom line results missed street analysts by $ 0.03 or 7.69 percent, at the same time, top line results fell short of analysts by $ 1.77 million or 25.73 percent.
Stock Performance
Shares of Chembio Diagnostics, Inc. traded up $ 0.04 or 0.88 percent on Wednesday, reaching $ 4.61 with volume of 1.06 million shares. Chembio Diagnostics, Inc. has traded high as $ 4.74 and has cracked $ 4.50 on the downward trend
The closing price of $ 4.61, representing a 103.11 % increase from the 52 week low of $ 2.25 and a 71.24 % decrease over the 52 week high of $ 15.89.
The company has a market capital of $ 92.94 million and is part of the Healthcare sector and Diagnostics & Research industry.
Conference Call
Chembio Diagnostics, Inc. will be hosting a conference call at 4:30 PM eastern time on 5th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website chembio.com
Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for HIV and Syphilis, and Zika virus. It also develops tests for malaria, Dengue virus, chikungunya virus, ebola, lassa, marburg, leptospirosis, Rickettsia typhi, Burkholderia pseudomallei, and Orientia tsutsugamushi.
